DogStem
Numerous scientific publications support the efficacy and safety of stem cells in the treatment of systemic diseases such as chronic kidney failure or inflammatory bowel disease (IBD).
In recent years, the intravenous use of stem cells has been investigated to treat numerous systemic and autoimmune diseases due to their immunomodulatory potential, but there is still no stem cell-based drug authorized for this use.
EquiCord is committed to the research and development of new, advanced therapy drugs that offer long-term solutions for veterinarians. Mesenchymal stem cells, thanks to their potent anti-inflammatory and immunomodulatory action, have proven to be an effective and safe treatment for numerous diseases, with a lasting effect after a single administration.
Inflammatory bowel disease (IBD) is a chronic, serious, and debilitating illness with a mortality rate exceeding 30%. It is characterized by vomiting, diarrhea, weight loss, fatigue, and a reduced quality of life.
Until now, IBD has been managed with high doses of immunosuppressants, which leads to serious side effects.
CORTICOSTEROID WITHDRAWAL
REMISSION OF CLINICAL SYMPTOMS
IMPROVING QUALITY OF LIFE